Director, Biologics Neurotherapeutic Development

National Institute of Neurological Disorders and Stroke (NINDS) is a leading supporter of biomedical research on disorders of the brain and the nervous system at the National Institutes of Health (NIH).  NINDS leads two major trans-NIH programs to support early translational efforts in biologics discovery and development – Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) and Ultra-rare Gene-based Therapy (URGenT) Network to advance the NIH mission and therapeutics discoveries towards clinical trials and ultimately patient use. 

Located within the Division of Translation Research (DTR), the Director, Biologics Neurotherapeutic Development oversees BPN-Biologics and URGenT Network to create significant synergy and efficiently accelerate therapeutics development designed to prevent and treat CNS disorders.  The office will focus on interactions with the academic and small business communities to enhance the cost effectiveness of both the BPN-Biologics and URGenT. The Director exercises broad influence regarding highly complex neurotherapeutics development and policy issues and provides leadership such as the following:

  • provide sound judgement on stage appropriate risk for NIH investments in neurotherapeutics development projects as well as appropriate data driven discontinuation decisions in a timely manner;
  • manage a portfolio of neurotherapeutics development projects spanning from early discovery to late development;
  • direct and influence teams to remain focused on critical path execution of milestone objectives in a timely fashion and within budget;
  • present the programs to the Extramural Community and presents on the programs at National Meetings as well as targeted foundations, webinars, and other forums;
  • supervise staff involved in programs related to neurotherapeutics development at NINDS.

Applicants with a Ph.D. or equivalent doctoral degree with substantial multidisciplinary scientific expertise in biologics development with experience advancing research ideas to the point of helping patients is highly desirable. The ideal candidate will have experience working in academia and industry and be a recognized expert in neurotherapeutics preclinical development, product optimization, preclinical scale up and manufacture and toxicology, regulatory affairs, and early human clinical trials.

The position will be filled under a Title 5 General Schedule (GS) 15 appointment. The salary is commensurate with the experience and a full package of Civil Service benefits is available, including retirement, health and life insurance, leave, and savings plan (401K equivalent).

Position Information:  Questions about this position may be directed to Dr. Amir Tamiz, Director, DTR amir.tamiz@nih.gov.

Who May Apply:  You must be a U.S. Citizen or U.S. National to be considered for this position. Foreign nationals or legal permanent residents are not eligible for consideration.  Selection for this position is dependent upon successful referral from a Supervisory Health Scientist Administrator announcement (GS-15 position) on https://www.usajobs.gov.  

Please make sure to apply to the Supervisory Health Scientist Administrator (Program Officer) GS-15 announcement link below scheduled from May 16 to May 26th.  

Delegated Examining (Open to the Public)

 Merit Promotion (Open to Status Candidates)

To stay up to date with all the exciting career opportunities with NINDS, please subscribe to our Job Announcements listserv.  Email listserv@list.nih.gov and include this language (without quotes) in the body of your email: "Subscribe NINDS-job-announcements your name".

All information provided by candidates will remain strictly confidential and will not be released outside the search process without a signed release from candidates. HHS and NIH are Equal Opportunity Employers.

Was this page helpful?
Form Approved OMB# 0925-0648 Exp. Date 06/2024